Teza Capital Management LLC Sells 1,321 Shares of Humana Inc. (NYSE:HUM)

Teza Capital Management LLC trimmed its holdings in Humana Inc. (NYSE:HUM - Free Report) by 24.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,140 shares of the insurance provider's stock after selling 1,321 shares during the period. Teza Capital Management LLC's holdings in Humana were worth $1,050,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Dodge & Cox raised its position in Humana by 106.7% in the 4th quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider's stock valued at $2,587,345,000 after buying an additional 5,264,045 shares during the last quarter. Vanguard Group Inc. raised its position in Humana by 15.8% in the 4th quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock valued at $3,254,899,000 after buying an additional 1,751,857 shares during the last quarter. Norges Bank purchased a new stake in Humana in the 4th quarter valued at $416,202,000. Pzena Investment Management LLC raised its position in Humana by 44.0% in the 4th quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock valued at $915,736,000 after buying an additional 1,103,132 shares during the last quarter. Finally, Boston Partners raised its position in Humana by 435.8% in the 4th quarter. Boston Partners now owns 1,098,702 shares of the insurance provider's stock valued at $279,236,000 after buying an additional 893,637 shares during the last quarter. 92.38% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research firms have recently issued reports on HUM. Mizuho upped their target price on Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Barclays upped their target price on Humana from $270.00 to $322.00 and gave the company an "equal weight" rating in a report on Friday, April 11th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $283.00 target price on shares of Humana in a report on Wednesday, February 12th. Raymond James raised Humana from a "market perform" rating to an "outperform" rating and set a $315.00 target price for the company in a report on Thursday, May 1st. Finally, Guggenheim started coverage on Humana in a report on Wednesday, April 9th. They issued a "buy" rating and a $326.00 target price for the company. Seventeen investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Humana presently has an average rating of "Hold" and an average price target of $286.81.

Humana Stock Performance

Shares of NYSE HUM traded down $2.33 during mid-day trading on Friday, hitting $224.81. The company had a trading volume of 1,673,666 shares, compared to its average volume of 1,779,843. The company has a market capitalization of $27.13 billion, a price-to-earnings ratio of 22.59, a P/E/G ratio of 2.05 and a beta of 0.49. Humana Inc. has a 1 year low of $212.45 and a 1 year high of $406.46. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The stock's 50-day moving average price is $261.17 and its 200-day moving average price is $268.77.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 EPS for the quarter, beating the consensus estimate of $10.07 by $1.51. Humana had a net margin of 1.02% and a return on equity of 11.70%. The firm had revenue of $32.11 billion during the quarter, compared to the consensus estimate of $32 billion. During the same period last year, the firm earned $7.23 EPS. The business's quarterly revenue was up 8.4% compared to the same quarter last year. On average, sell-side analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.57%. The ex-dividend date of this dividend is Friday, June 27th. Humana's dividend payout ratio is currently 25.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.